ORLANDO, Florida — A low dose of the sodium-glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin combined with insulin improved glycemic control and slowed kidney function decline in adolescents ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

Diabetes is the most common cause of chronic kidney disease (CKD). Around 33 percent of adults with diabetes also have CKD. When diabetes causes CKD, its sometimes called diabetic kidney disease.

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss? There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether ...

People lost substantially more weight when they took Eli Lilly's diabetes drug Mounjaro than Novo Nordisk's Ozempic, with roughly the same side effects, drop-out rate and benefit for diabetes, ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows. The two drugs are metformin, one of the most widely used ...

There has been a lot of chatter over the past year about the positive impacts of diabetes medications—like Ozempic—on a slew of serious health conditions. Now, there’s a new type of prescription ...